An Integrated Computational Analysis of High-Risk SNPs in Angiopoietin-like Proteins (ANGPTL3 and ANGPTL8) Reveals Perturbed Protein Dynamics Associated with Cancer

• Published in: Molecules (Basel, Switzerland) Switzerland), 2023-06, Vol.28 (12), p.4648
• Main Authors: Iqbal, Sajid, Begum, Farida, Nyamai, Dorothy Wavinya, Jalal, Nasir, Shaw, Peter
• Format: Article
• Language: English
• Subjects: Algorithms; Amino acids; Angiopoietin; Angiopoietin-Like Protein 3; Angiopoietin-Like Protein 8; angiopoietin-like proteins; Angiopoietin-like Proteins - genetics; Binding sites; Breast cancer; Breast carcinoma; Breast Neoplasms; Cancer; Carcinoma; Carcinoma, Renal Cell - genetics; Cell growth; Development and progression; Disease; Down-regulation; Female; Gene expression; Genetic aspects; Genetic polymorphisms; Glioblastoma; Glycoproteins; Growth factors; Health aspects; high-risk non-synonymous SNPs; Humans; In vivo methods and tests; Kidney Neoplasms; Kidneys; Kinases; Ligands; Metastasis; Mutation; Nucleotides; Oncology, Experimental; Peptide Hormones - genetics; Polymorphism, Single Nucleotide; protein structure and function; Proteins; Renal cell carcinoma; Sarcoma; Single-nucleotide polymorphism; Survival
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules28124648

Angiopoietin-like proteins (ANGPTL) constitute a family of eight proteins (1-8) which play a pivotal role in the regulation of various pathophysiological processes. The current study sought to identify high-risk, "non-synonymous, single-nucleotide polymorphisms" (nsSNPs) in both ANGPTL3 and ANGPTL8 to evaluate the role that these nsSNPs play in various types of cancer. We retrieved a total of 301 nsSNPs from various databases; 79 of these candidates constitute high-risk nsSNPs. Moreover, we identified eleven high-risk nsSNPs that cause various types of cancer: seven candidates for ANGPTL3 (L57H, F295L, L309F, K329M, R332L, S348C, and G409R) and four candidates for ANGPTL8 (P23L, R85W, R138S, and E148D). Protein-protein interaction analysis revealed a strong association of ANGPTL proteins with several tumor-suppressor proteins such as ITGB3, ITGAV, and RASSF5. 'Gene-expression profiling interactive analysis' (GEPIA) showed that expression of ANGPTL3 is significantly downregulated in five cancers: sarcoma (SARC); cholangio carcinoma (CHOL); kidney chromophobe carcinoma (KICH); kidney renal clear cell carcinoma (KIRC); and kidney renal papillary cell carcinoma (KIRP). GEPIA also showed that expression of ANGPTL8 remains downregulated in three cancers: CHOL; glioblastoma (GBM); and breast invasive carcinoma (BRCA). Survival rate analysis indicated that both upregulation and downregulation of ANGPTL3 and ANGPTL8 leads to low survival rates in various types of cancer. Overall, the current study revealed that both ANGPTL3 and ANGPTL8 constitute potential prognostic biomarkers for cancer; moreover, nsSNPs in these proteins might lead to the progression of cancer. However, further in vivo investigation will be helpful to validate the role of these proteins in the biology of cancer.